Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Charles
- PMID: 33658235
- DOI: 10.1136/annrheumdis-2021-220164
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Charles
Keywords: Covid-19; biological therapy; epidemiology; glucocorticoids; therapeutics.
Conflict of interest statement
Competing interests: Editor, ARD.
Comment on
-
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.Ann Rheum Dis. 2020 Sep;79(9):1143-1151. doi: 10.1136/annrheumdis-2020-218479. Epub 2020 Jul 20. Ann Rheum Dis. 2020. PMID: 32719045 Free PMC article. Clinical Trial.
-
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.Ann Rheum Dis. 2023 May;82(5):e108. doi: 10.1136/annrheumdis-2021-219986. Epub 2021 Feb 15. Ann Rheum Dis. 2023. PMID: 33589440 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
